Dataset from A Randomised, Double-blind, Placebo-controled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug Naive or Previously Treated (6 Weeks Washout) Type 2 Diabetic Patients With Insufficient Glycemic Control
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
To investigate efficacy, safety and tolerability of BI 1356 versus placebo
创建时间：
2025-12-08
